Evidence map›Paper›PMID 35453507›Full record

ArticleBiomedicines2022

Effects of Human RelA Transgene on Murine Macrophage Inflammatory Responses.

Stamatia Papoutsopoulou, Lorna Morris, Andrew Bayliff, Thomas Mair, Hazel England, Massimiliano Stagi, François Bergey, Mohammad Tauqeer Alam, Raheleh Sheibani-Tezerji, Philip Rosenstiel and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Stamatia PapoutsopoulouLydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-6665-8508
Lorna MorrisLifeGlimmer GmbH, Markelstr. 39A, 12163 Berlin, Germany.ORCID 0000-0002-3441-803X
Andrew BayliffThe Henry Wellcome Laboratories of Molecular & Cellular Gastroenterology, Department of Infection Biology & Microbiomes, Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3GE, UK.
Thomas MairThe Henry Wellcome Laboratories of Molecular & Cellular Gastroenterology, Department of Infection Biology & Microbiomes, Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3GE, UK.
Hazel EnglandLydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Massimiliano StagiDepartment of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7BE, UK.
François BergeyLifeGlimmer GmbH, Markelstr. 39A, 12163 Berlin, Germany.
Mohammad Tauqeer AlamWarwick Medical School, Bioinformatics RTP, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0002-6872-0691
Raheleh Sheibani-TezerjiInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, 6708 WE Kiel, Germany.ORCID 0000-0002-1025-646X
Philip RosenstielInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, 6708 WE Kiel, Germany.
Werner MüllerLydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-1297-9725
Vitor A P Martins Dos SantosLifeGlimmer GmbH, Markelstr. 39A, 12163 Berlin, Germany.ORCID 0000-0002-2352-9017
Barry J CampbellThe Henry Wellcome Laboratories of Molecular & Cellular Gastroenterology, Department of Infection Biology & Microbiomes, Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3GE, UK.ORCID 0000-0002-7407-012X
University of Liverpool · GBLifeGlimmer (Germany) · DEChristian-Albrechts-Universität zu Kiel · DEUniversity of Manchester · GBUnited Arab Emirates University · AEUniversity of Thessaly · GR

Funding

European Union Seventh Framework Programme (FP7 - Health) under grant agreement ID number 305564.
6 · The paper itself

Abstract

The NFκB transcription factors are major regulators of innate immune responses, and NFκB signal pathway dysregulation is linked to inflammatory disease. Here, we utilised bone marrow-derived macrophages from the p65-DsRedxp/IκBα-eGFP transgenic strain to study the functional implication of xenogeneic (human) RelA(p65) protein introduced into the mouse genome. Confocal imaging showed that human RelA is expressed in the cells and can translocate to the nucleus following activation of Toll-like receptor 4. RNA sequencing of lipid A-stimulated macrophages, revealed that human RelA impacts on murine gene transcription, affecting both non-NFκB and NFκB target genes, including immediate-early and late response genes, e.g.,

Indexed as

inflammationlipid AlipopolysaccharidemacrophageNFκBRelA(p65)toll-like receptortumour necrosis factor

Identifiers

PMID35453507
PMCPMC9027775
OpenAlexW4220949026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.